
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
In vivo hematopoietic stem cell modification by mRNA delivery
Laura Breda, Tyler E. Papp, Michael Triebwasser, et al.
Science (2023) Vol. 381, Iss. 6656, pp. 436-443
Open Access | Times Cited: 153
Laura Breda, Tyler E. Papp, Michael Triebwasser, et al.
Science (2023) Vol. 381, Iss. 6656, pp. 436-443
Open Access | Times Cited: 153
Showing 1-25 of 153 citing articles:
Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo
Meirui An, Aditya Raguram, Samuel W. Du, et al.
Nature Biotechnology (2024) Vol. 42, Iss. 10, pp. 1526-1537
Open Access | Times Cited: 89
Meirui An, Aditya Raguram, Samuel W. Du, et al.
Nature Biotechnology (2024) Vol. 42, Iss. 10, pp. 1526-1537
Open Access | Times Cited: 89
mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications
Yu‐Shiuan Wang, Monika Kumari, Guanhong Chen, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 77
Yu‐Shiuan Wang, Monika Kumari, Guanhong Chen, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 77
mRNA-based therapeutics: looking beyond COVID-19 vaccines
Hamideh Parhiz, Elena N. Atochina‐Vasserman, Drew Weissman
The Lancet (2024) Vol. 403, Iss. 10432, pp. 1192-1204
Closed Access | Times Cited: 77
Hamideh Parhiz, Elena N. Atochina‐Vasserman, Drew Weissman
The Lancet (2024) Vol. 403, Iss. 10432, pp. 1192-1204
Closed Access | Times Cited: 77
The 60-year evolution of lipid nanoparticles for nucleic acid delivery
Pieter R. Cullis, Philip L. Felgner
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 9, pp. 709-722
Closed Access | Times Cited: 72
Pieter R. Cullis, Philip L. Felgner
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 9, pp. 709-722
Closed Access | Times Cited: 72
Physiological Barriers and Strategies of Lipid‐Based Nanoparticles for Nucleic Acid Drug Delivery
Mingdi Hu, Xiaoyan Li, Zhen You, et al.
Advanced Materials (2023)
Closed Access | Times Cited: 53
Mingdi Hu, Xiaoyan Li, Zhen You, et al.
Advanced Materials (2023)
Closed Access | Times Cited: 53
Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation
Kexin Su, Lu Shi, Tao Sheng, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 47
Kexin Su, Lu Shi, Tao Sheng, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 47
Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cells
Xizhen Lian, Sumanta Chatterjee, Yehui Sun, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 9, pp. 1409-1417
Closed Access | Times Cited: 31
Xizhen Lian, Sumanta Chatterjee, Yehui Sun, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 9, pp. 1409-1417
Closed Access | Times Cited: 31
Frameworks for transformational breakthroughs in RNA-based medicines
John R. Androsavich
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 6, pp. 421-444
Closed Access | Times Cited: 26
John R. Androsavich
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 6, pp. 421-444
Closed Access | Times Cited: 26
IL7 increases targeted lipid nanoparticle–mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation
Caitlin M. Tilsed, Barzan A. Sadiq, Tyler E. Papp, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 13
Open Access | Times Cited: 18
Caitlin M. Tilsed, Barzan A. Sadiq, Tyler E. Papp, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 13
Open Access | Times Cited: 18
Lipid nanoparticle-based strategies for extrahepatic delivery of nucleic acid therapies – challenges and opportunities
Jens B. Simonsen
Journal of Controlled Release (2024) Vol. 370, pp. 763-772
Closed Access | Times Cited: 18
Jens B. Simonsen
Journal of Controlled Release (2024) Vol. 370, pp. 763-772
Closed Access | Times Cited: 18
EGFR-targeted ionizable lipid nanoparticles enhance in vivo mRNA delivery to the placenta
Hannah C. Geisler, Aditi A Ghalsasi, Hannah C Safford, et al.
Journal of Controlled Release (2024) Vol. 371, pp. 455-469
Closed Access | Times Cited: 17
Hannah C. Geisler, Aditi A Ghalsasi, Hannah C Safford, et al.
Journal of Controlled Release (2024) Vol. 371, pp. 455-469
Closed Access | Times Cited: 17
Advanced Delivery Systems for Gene Editing: A Comprehensive Review from the GenE-HumDi COST Action Working group
Alessia Cavazza, Francisco J Molina-Estévez, Álvaro Plaza Reyes, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 1, pp. 102457-102457
Open Access | Times Cited: 2
Alessia Cavazza, Francisco J Molina-Estévez, Álvaro Plaza Reyes, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 1, pp. 102457-102457
Open Access | Times Cited: 2
Nature-inspired platform nanotechnology for RNA delivery to myeloid cells and their bone marrow progenitors
Stijn R. J. Hofstraat, Tom Anbergen, Robby Zwolsman, et al.
Nature Nanotechnology (2025)
Open Access | Times Cited: 2
Stijn R. J. Hofstraat, Tom Anbergen, Robby Zwolsman, et al.
Nature Nanotechnology (2025)
Open Access | Times Cited: 2
Targeted Delivery of mRNA with Polymer–Lipid Nanoparticles for In Vivo Base Editing
Qimingxing Chen, Yan Chang, Xiaoyan He, et al.
ACS Nano (2025)
Closed Access | Times Cited: 2
Qimingxing Chen, Yan Chang, Xiaoyan He, et al.
ACS Nano (2025)
Closed Access | Times Cited: 2
Nano-bio interactions in mRNA nanomedicine: Challenges and opportunities for targeted mRNA delivery
Qimanguli Saiding, Zhongyang Zhang, Shuying Chen, et al.
Advanced Drug Delivery Reviews (2023) Vol. 203, pp. 115116-115116
Closed Access | Times Cited: 29
Qimanguli Saiding, Zhongyang Zhang, Shuying Chen, et al.
Advanced Drug Delivery Reviews (2023) Vol. 203, pp. 115116-115116
Closed Access | Times Cited: 29
Chimeric antigen receptor therapy meets mRNA technology
Jiacai Wu, Weigang Wu, Boping Zhou, et al.
Trends in biotechnology (2023) Vol. 42, Iss. 2, pp. 228-240
Open Access | Times Cited: 23
Jiacai Wu, Weigang Wu, Boping Zhou, et al.
Trends in biotechnology (2023) Vol. 42, Iss. 2, pp. 228-240
Open Access | Times Cited: 23
Nucleic acid-based drugs for patients with solid tumours
Sebastian G. Huayamares, David Loughrey, Hyejin Kim, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 6, pp. 407-427
Closed Access | Times Cited: 15
Sebastian G. Huayamares, David Loughrey, Hyejin Kim, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 6, pp. 407-427
Closed Access | Times Cited: 15
Placenta-tropic VEGF mRNA lipid nanoparticles ameliorate murine pre-eclampsia
Kelsey L. Swingle, Alex G. Hamilton, Hannah C. Safford, et al.
Nature (2024)
Closed Access | Times Cited: 14
Kelsey L. Swingle, Alex G. Hamilton, Hannah C. Safford, et al.
Nature (2024)
Closed Access | Times Cited: 14
The clinical impact of mRNA therapeutics in the treatment of cancers, infections, genetic disorders, and autoimmune diseases
Roham Deyhimfar, Mehrnaz Izady, Mohammadreza Shoghi, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26971-e26971
Open Access | Times Cited: 13
Roham Deyhimfar, Mehrnaz Izady, Mohammadreza Shoghi, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26971-e26971
Open Access | Times Cited: 13
Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR–Cas9 ribonucleoprotein
Kai Chen, Hesong Han, Sheng Zhao, et al.
Nature Biotechnology (2024)
Open Access | Times Cited: 13
Kai Chen, Hesong Han, Sheng Zhao, et al.
Nature Biotechnology (2024)
Open Access | Times Cited: 13
Unlocking the Therapeutic Applicability of LNP-mRNA: Chemistry, Formulation, and Clinical Strategies
Xiaonan Huang, Yishan Ma, Guanghui Ma, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 11
Xiaonan Huang, Yishan Ma, Guanghui Ma, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 11
Designing drug delivery systems for cell therapy
Liwen Wang, Yongsheng Gao, Zhaoqianqi Feng, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 11, pp. 944-959
Closed Access | Times Cited: 11
Liwen Wang, Yongsheng Gao, Zhaoqianqi Feng, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 11, pp. 944-959
Closed Access | Times Cited: 11
In utero delivery of targeted ionizable lipid nanoparticles facilitates in vivo gene editing of hematopoietic stem cells
Rohan Palanki, John S. Riley, Sourav K. Bose, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 32
Closed Access | Times Cited: 11
Rohan Palanki, John S. Riley, Sourav K. Bose, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 32
Closed Access | Times Cited: 11
Enhancing prime editing in hematopoietic stem and progenitor cells by modulating nucleotide metabolism
Sébastien Levesque, Andrea Cosentino, Archana Verma, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 10
Sébastien Levesque, Andrea Cosentino, Archana Verma, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 10
Recent Therapeutic Gene Editing Applications to Genetic Disorders
Éric Deneault
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4147-4185
Open Access | Times Cited: 9
Éric Deneault
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4147-4185
Open Access | Times Cited: 9